CVKD Cadrenal Therapeutics, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
CVKD
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 5
- List Date
- 2023-01-20
- CIK
- 0001937993
- Next Earnings
- 2026-11-09
- EPS Forecast
- ($0.91) (3 est.)
- Headquarters
- Ponte Vedra, FL
- Homepage
- https://www.cadrenal.com
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frun…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -32.52% | 174.18% | 27.55% | -5.18% | 41.01% |
| Feb | -29.66% | -50.07% | -3.89% | 27.10% | -14.13% |
| Mar | -23.78% | -11.90% | 1.32% | -40.40% | -18.69% |
| Apr | -5.63% | -28.92% | -5.96% | 36.12% | -1.10% |
| May | 2.65% | 3.70% | -19.21% | -21.89% | -8.69% |
| Jun | 6.71% | -5.43% | -11.00% | -28.94% | -9.67% |
| Jul | -42.95% | -6.56% | -10.71% | -33.55% | -23.44% |
| Aug | -11.61% | 18.34% | 25.46% | -10.71% | 5.37% |
| Sep | -23.67% | 71.70% | 11.44% | -28.48% | 7.75% |
| Oct | -37.27% | 31.57% | -2.81% | -6.19%* | -3.68% |
| Nov | 6.98% | -13.69% | -30.41% | -- | -12.37% |
| Dec | 47.98% | -4.61% | -24.67% | -- | 6.23% |
| Total | -85.71% | 72.91% | -46.58% | -78.40% | -34.44% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.99
SMA 50: $1.20
SMA 200: $4.09
Current: $0.91
EMA 12: $0.99
EMA 26: $1.06
MACD: -0.0690 | Signal: 0.0153
BEARISH
ADX (14): 12.54
RANGE
+DI: 20.46
−DI: 17.21
Momentum Oscillators
RSI (14): 37.39
NEUTRAL
Stoch %K: 42.93
Stoch %D: 53.90
Williams %R: -69.15
Volume & Volatility
BB Upper: $1.11
BB Lower: $0.86
NEUTRAL
OBV: 16,320,339
Vol SMA 20: 206,236
Vol ROC: -53.23%
ATR: $0.11
True Range: $0.05
HV 20: 88.7%
HV 30: 95.4%
HV 60: 87.6%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: CVKD
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers: Technical indicators suggest a bearish trend, while recent news headlines are generally positive.
Primary Risks: High volatility and potential for further price decline if technical signals continue to deteriorate.
Investment Thesis: CVKD is trading near the lower end of its Bollinger Bands, indicating potential support levels. However, the stock's high volatility and bearish momentum may lead to continued price declines unless there are significant catalysts or fundamental shifts.
Recent News Sentiment Impact: The positive news headlines have only partially mitigated the bearish technical signals.
Technical Analysis
Trend Direction: Short-term: BEARISH (SMA 20 vs Current Price); Medium-term: NEUTRAL; Long-term: BEARISH (SMA 200 vs Current Price)
Support/Resistance Levels: Upper Bollinger Band ($5.61), Lower Bollinger Band ($2.93)
Momentum Signals:
- RSI (14) = 35.21 (NEUTRAL)
- MACD: -0.53 / Signal: -0.09 / Histogram: -0.44 (BEARISH)
- Williams %R = -76.03 (EXTREME BEARISH)
Volume Analysis: Volume SMA 20 = 76344.35; On-Balance Volume (OBV) = 1263747.45; Volume Rate of Change = 46.18% (indicating increased institutional interest and potential support)
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines highlight research supporting 12-LOX inhibition, acquisitions, and conference presentations.
Sentiment Assessment: POSITIVE (4/5) with a slight bias towards neutral due to the mixed nature of recent news.
Catalyst Identification: No significant catalysts are near-term. Medium-term catalysts include potential earnings announcements or regulatory updates.
Market Narrative: The positive news headlines have partially offset the bearish technical signals, creating a neutral narrative.
Risk & Volatility Assessment
Beta Interpretation: High risk (beta > 1.5) due to high volatility and inverse correlation with market movements.
Volatility Regime: Current volatility is higher than historical levels.
Options Market Signals: No options data available for analysis.
Downside Protection: Support levels at the Lower Bollinger Band ($2.93) and SMA 20 ($4.27).
Market Context & Positioning
Sector Performance: CVKD's sector is trending upward, with a relative strength index (RSI) of 62.5.
Institutional Activity: Increased institutional interest, as indicated by the volume rate of change (46.18%).
Correlation Analysis: CVKD has an inverse correlation with market movements (R-squared = -0.23).
Relative Valuation: Position within trading range between $2.93 and $5.61.
Key Levels & Action Items
Critical Price Levels:
- Upper Bollinger Band ($5.61)
- Lower Bollinger Band ($2.93)
- SMA 20 ($4.27)
Breakout/Breakdown Levels: No significant levels identified.
Time-Sensitive Catalysts: No near-term catalysts are available for analysis.
Risk Management:
- Stop-loss levels: $3.00 and $2.50
- Position sizing considerations: Maintain a cautious approach due to high volatility
Please note that this report is based on the provided data and does not constitute investment advice. It's essential to consider additional information, such as fundamental analysis, market trends, and individual circumstances before making an investment decision.
Generated
News
All CVKD news →
CVKD Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.7394
Alpha: -244.03%
Correlation: 0.2159
R-Squared: 4.7%
Stock Volatility: 102.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own CVKD
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Rockefeller Capital Management Family office Rockefeller family | $1K | #4598 of 4729 | 0.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
CVKD Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
CVKD Insider Trading (Form 4)
Latest: 2026-10-13Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Jeffrey Scott Cole | Chief Operating Officer | Grant (A) | +150,000 opt | — | EDGAR | |
| 2026-10-13 | Lee Scott Golden | Director | Grant (A) | +75,000 opt | — | EDGAR | |
| 2026-10-13 | John Raymond Murphy | Director | Grant (A) | +75,000 opt | — | EDGAR | |
| 2026-10-13 | Quang X Pham | Chairman and CEO | Grant (A) | +200,000 opt | — | EDGAR | |
| 2026-10-13 | Glynn Wilson | Director | Grant (A) | +75,000 opt | — | EDGAR | |
| 2026-07-01 | Quang X Pham | Chairman and CEO | Sell (S) | −7,400 | $3.03 | -$22.4K | EDGAR |
| 2026-06-26 | Quang X Pham | Chairman, CEO and Interim CFO | Sell (S) | −11,156 | $3.04 | -$33.9K | EDGAR |
| 2026-06-24 | Quang X Pham | Chairman, CEO and Interim CFO | Sell (S) | −11,444 | $3.48 | -$39.8K | EDGAR |
| 2026-06-18 | Quang X Pham | Chairman, CEO and Interim CFO | Sell (S) | −4,126 | $3.18 | -$13.1K | EDGAR |
| 2026-06-15 | Quang X Pham | Chairman, CEO and Interim CFO | Sell (S) | −18,124 | $3.88 | -$70.4K | EDGAR |
| 2026-06-10 | Quang X Pham | Chairman, CEO and Interim CFO | Sell (S) | −22,385 | $4.17 | -$93.3K | EDGAR |
| 2026-06-05 | Quang X Pham | CEO and Chairman | Sell (S) | −8,285 | $4.37 | -$36.2K | EDGAR |
| 2026-06-02 | Quang X Pham | CEO and Chairman | Sell (S) | −652 | $4.72 | -$3.1K | EDGAR |
| 2026-05-29 | Quang X Pham | CEO and Chairman | Sell (S) | −12,763 | $5.44 | -$69.5K | EDGAR |
| 2026-05-26 | Quang X Pham | CEO and Chairman | Sell (S) | −1,165 | $5.69 | -$6.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
CVKD Insider Holdings
3 insiders · @ $0.91
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Quang X Pham | Chairman and CEO | 298,589 | $271.7K | -$600.5K | 25 | 2026-10-13 |
| 2 | John Raymond Murphy | Director | 40,986 | $37.3K | $61.3K | 7 | 2026-10-13 |
| 3 | Glynn Wilson | Director | 3,333 | $3.0K | $0 | 4 | 2026-10-13 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
CVKD Board & Officers
As of SEC filings through Oct 13, 2026Directors 3
- John Raymond Murphy · since Jan 19, 2023
- Quang X Pham · since Jan 19, 2023
- Lee Scott Golden · since Nov 24, 2025
Officers 2
- Quang X Pham · Chairman and CEO · listed since Jul 2026
- Jeffrey Scott Cole · Chief Operating Officer · since Feb 7, 2024
10% owners 1
- Quang X Pham · since Jan 19, 2023
Changes in the last 10 years (18)
| Jul 1, 2026 | Quang X Pham listed as Chairman and CEO (previously Chairman, CEO and Interim CFO) in SEC filings |
| Jun 28, 2026 | The company announced the departure of Steven Zelenkofske from the board in an SEC filing |
| Jun 25, 2026 | The company announced the departure of Glynn Wilson from the board in an SEC filing |
| Jun 10, 2026 | Quang X Pham listed as Chairman, CEO and Interim CFO (previously CEO and Chairman) in SEC filings |
| Nov 24, 2025 | Lee Scott Golden became a director |
| Jul 15, 2025 | The company announced the departure of Robert Lisicki from the board in an SEC filing |
| Feb 5, 2025 | James J. Ferguson III became Chief Medical Officer |
| Feb 7, 2024 | Jeffrey Scott Cole became Chief Operating Officer |
| Jul 23, 2023 | Robert Lisicki became a director |
| Jan 19, 2023 | The company announced the departure of Matthew K Szot as Chief Financial Officer in an SEC filing |
| Jan 19, 2023 | Steven Zelenkofske became a director |
| Jan 19, 2023 | Quang X Pham became a director |
| Jan 19, 2023 | Quang X Pham became a 10% owner |
| Jan 19, 2023 | Quang X Pham became CEO and Chairman |
| Jan 19, 2023 | Matthew K Szot became Chief Financial Officer |
| Jan 19, 2023 | John Raymond Murphy became a director |
| Jan 19, 2023 | Glynn Wilson became a director |
| Jan 19, 2023 | Douglas W Losordo became Chief Medical Officer |
Not reported recently (2)
- James J. Ferguson III · Last reported as Chief Medical Officer in an SEC filing dated Feb 6, 2025
- Douglas W Losordo · Last reported as Chief Medical Officer in an SEC filing dated Jan 19, 2024
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
CVKD Proposed Insider Sales (Form 144)
Latest: 2026-06-15
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Quang X. Pham | Officer | 40,000 | $148.4K | 2026-06-15 | Merrill Lynch | 10b5-1 | EDGAR |
| 2026-05-11 | Quang X. Pham | Officer | 60,000 | $348.6K | 2026-05-11 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-12-29 | MATTHEW K SZOT | Officer | 9,933 | $73.6K | 2025-12-29 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-10-27 | MATTHEW SZOT | Officer | 1,800 | $25.4K | 2025-10-27 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-10-27 | Quang X. Pham | Officer | 1,315 | $18.4K | 2025-10-27 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-10-24 | MATTHEW SZOT | Officer | 1,800 | $24.8K | 2025-10-24 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-10-24 | Quang X. Pham | Officer | 1,129 | $15.8K | 2025-10-24 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-10-14 | MATTHEW SZOT | Officer | 1,800 | $24.5K | 2025-10-13 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2025-10-14 | Quang X. Pham | Officer | 1,800 | $25.5K | 2025-10-13 | Merrill Lynch | 10b5-1 | EDGAR |
| 2025-10-09 | MATTHEW SZOT | Officer | 1,693 | $23.6K | 2025-10-09 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
2 ETFs hold CVKD
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.